Arkansas 2025 Regular Session

Arkansas Senate Bill SB140

Introduced
1/29/25  
Refer
1/29/25  
Refer
2/5/25  

Caption

To Mandate The Use Of Biosimilar Medicines Under Health Benefit Plans; To Require A Healthcare Provider To Prescribe Biosimilar Medicines; And To Improve Access To Biosimilar Medicines.

Companion Bills

No companion bills found.

Similar Bills

MN HF1076

Pharmacy benefit managers and health carriers required to include lower-cost drugs in their formularies, and formulary structure and formulary tiering for each health plan required to give preference to the drug with the lowest out-of-pocket cost to the patient.

MN SF1876

Pharmacy benefit managers and health carriers inclusion of lower-cost drugs in formularies requirement provision and lowest out-of-pocket-cost drug to patient formulary tiering preference provision

VA HB2329

Health insurance; prescription drug formularies.

MD SB393

Health Insurance - Prescription Drug Formularies and Coverage for Generic Drugs and Biosimilars

MD HB529

Health Insurance - Prescription Drug Formularies and Coverage for Generic Drugs and Biosimilars

TX SB241

Relating to written notification provided by drug manufacturers regarding the cause of generic or biosimilar insulin prescription drug unavailability.

TX SB190

Relating to the prescription and pharmaceutical substitution of biological products.

TN SB1382

AN ACT to amend Tennessee Code Annotated, Title 8; Title 56; Title 63; Title 68 and Title 71, relative to step therapy.